It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MKKGY’s FA Score shows that 1 FA rating(s) are green whileMRK’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MKKGY’s TA Score shows that 5 TA indicator(s) are bullish while MRK’s TA Score has 5 bullish TA indicator(s).
MKKGY (@Pharmaceuticals: Other) experienced а +4.58% price change this week, while MRK (@Pharmaceuticals: Major) price change was +2.36% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.63%. For the same industry, the average monthly price growth was -1.43%, and the average quarterly price growth was -9.80%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.16%. For the same industry, the average monthly price growth was -2.53%, and the average quarterly price growth was -8.74%.
MKKGY is expected to report earnings on Aug 07, 2025.
MRK is expected to report earnings on Jul 29, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Pharmaceuticals: Major (+2.16% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
MKKGY | MRK | MKKGY / MRK | |
Capitalization | 76.6B | 332B | 23% |
EBITDA | 6.45B | 6.91B | 93% |
Gain YTD | -2.759 | -19.049 | 14% |
P/E Ratio | 21.41 | 935.64 | 2% |
Revenue | 22.3B | 60.1B | 37% |
Total Cash | 1.72B | 7.09B | 24% |
Total Debt | 10.6B | 35.1B | 30% |
MKKGY | MRK | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 13 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 29 Undervalued | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 67 | 70 | |
SMR RATING 1..100 | 70 | 25 | |
PRICE GROWTH RATING 1..100 | 74 | 64 | |
P/E GROWTH RATING 1..100 | 70 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MRK's Valuation (10) in the Pharmaceuticals Major industry is in the same range as MKKGY (29) in the null industry. This means that MRK’s stock grew similarly to MKKGY’s over the last 12 months.
MKKGY's Profit vs Risk Rating (67) in the null industry is in the same range as MRK (70) in the Pharmaceuticals Major industry. This means that MKKGY’s stock grew similarly to MRK’s over the last 12 months.
MRK's SMR Rating (25) in the Pharmaceuticals Major industry is somewhat better than the same rating for MKKGY (70) in the null industry. This means that MRK’s stock grew somewhat faster than MKKGY’s over the last 12 months.
MRK's Price Growth Rating (64) in the Pharmaceuticals Major industry is in the same range as MKKGY (74) in the null industry. This means that MRK’s stock grew similarly to MKKGY’s over the last 12 months.
MKKGY's P/E Growth Rating (70) in the null industry is in the same range as MRK (100) in the Pharmaceuticals Major industry. This means that MKKGY’s stock grew similarly to MRK’s over the last 12 months.
MKKGY | MRK | |
---|---|---|
RSI ODDS (%) | 2 days ago74% | 2 days ago66% |
Stochastic ODDS (%) | 2 days ago52% | 2 days ago62% |
Momentum ODDS (%) | 2 days ago68% | 3 days ago47% |
MACD ODDS (%) | 2 days ago65% | 2 days ago53% |
TrendWeek ODDS (%) | 2 days ago64% | 2 days ago50% |
TrendMonth ODDS (%) | 2 days ago61% | 2 days ago43% |
Advances ODDS (%) | 2 days ago64% | 26 days ago48% |
Declines ODDS (%) | 5 days ago54% | 10 days ago48% |
BollingerBands ODDS (%) | 2 days ago82% | 2 days ago64% |
Aroon ODDS (%) | 2 days ago68% | 2 days ago39% |
A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.
Ticker / NAME | Correlation To MKKGY | 1D Price Change % | ||
---|---|---|---|---|
MKKGY | 100% | +1.64% | ||
MKGAF - MKKGY | 49% Loosely correlated | -3.55% | ||
AMPH - MKKGY | 25% Poorly correlated | +2.16% | ||
ZTS - MKKGY | 25% Poorly correlated | +0.92% | ||
SUPN - MKKGY | 25% Poorly correlated | +1.65% | ||
INDV - MKKGY | 24% Poorly correlated | +13.86% | ||
More |
A.I.dvisor indicates that over the last year, MRK has been loosely correlated with AZN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then AZN could also see price increases.